<DOC>
	<DOCNO>NCT00452725</DOCNO>
	<brief_summary>1 . Clinical Objective : To improve growth child 2 . Genetic objective : A study genetics syndrome</brief_summary>
	<brief_title>Effect MAXOMAT ® Growth Small Children NOONAN 's Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Noonan Syndrome</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Children adolescents Noonan 's syndrome height &lt; 2 SD progressive cardiopathy Age &lt; 3 year Height ≥ 2 SD The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>